SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-025714
Filing Date
2018-05-07
Accepted
2018-05-07 16:35:00
Documents
48
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv491822_10-q.htm 10-Q 291957
2 EXHIBIT 31.1 tv491822_ex31-1.htm EX-31.1 10920
3 EXHIBIT 31.2 tv491822_ex31-2.htm EX-31.2 10883
4 EXHIBIT 32.1 tv491822_ex32-1.htm EX-32.1 4642
5 EXHIBIT 32.2 tv491822_ex32-2.htm EX-32.2 4433
  Complete submission text file 0001144204-18-025714.txt   2653611

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20180331.xml EX-101.INS 576970
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20180331.xsd EX-101.SCH 26281
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20180331_cal.xml EX-101.CAL 31183
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20180331_def.xml EX-101.DEF 160949
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20180331_lab.xml EX-101.LAB 220228
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20180331_pre.xml EX-101.PRE 185400
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 18811723
SIC: 2834 Pharmaceutical Preparations